BiotechTube
Home/Hemab Therapeutics/Anant Murthy, PhD
AM

Anant Murthy, PhD

Chief Operating Officer

Hemab Therapeutics

Therapeutic Areas

Rare Bleeding DisordersThrombotic Disorders

Hemab Therapeutics Pipeline

DrugIndicationPhase
SutacimigGlanzmann ThrombastheniaPhase 2/3
HMB-002Von Willebrand DiseasePhase 1/2